Toku is creating a world focused on preventive healthcare, using the eye as a window to our health. We believe every person in the world should have access to early diagnosis of health conditions before it’s too late. 

How? by developing tools using AI and retinal images to enable accessible healthcare for early
and accurate diagnosis of health conditions to empower everyday individuals. 

The retina has long been recognized as a unique window into an individual’s health, as the biomarkers present in retinal images may provide valuable insights into aging, inflammatory health, neurological health, and cardiovascular health. 

BioAge

Not all people age equally. Every person has two ages: our chronological age (how old you are) and our biological age. Biological age (or BioAge) is a measure of how well our cells, tissues and organs are aging. Toku’s BioAge product determines a person’s biological age, which can give an indication of their overall health, by looking at vascular, metabolic, inflammatory and lifestyle indicators present in the retinal image. By knowing our BioAge earlier, we can make conscious health choices to improve our health. Unlike our chronological age, our BioAge is not fixed.

BioAge uses retinal images and hence is non-invasive, time efficient, cost effective, and can be delivered by trusted healthcare providers.  The retinal vasculature allows direct non-invasive visualization of the body’s microvasculature, as it is the only part of the body where scientists and clinicians can directly assess the health of an individual’s neuro-vascular tissues.

Toku’s  AI platform utilizes a revolutionary, patented method to evaluate more than 23 million technical parameters and 12 biological parameters in each retinal image, to produce a BioAge outcome. The AI engine has learned patterns from images from over 1.3 million retinal images to recognize the various features of health.
Cardiovascular Screening (CLAiR)
Cardiovascular disease is the leading caus

AI/ML

Biotechnology

Health Care

Health Diagnostics

Medical Devices

Toku Eyes

Toku Eyes' headquarters in Auckland, New Zealand

Ehsan Vaghefi

Kai C.

Gerard Wallace

Kate Blackbourn

Francesca Logan

The Engineering and Development Team at Toku Eyes is responsible for developing and maintaining the company's AI-driven healthcare tools, specifically those analyzing retinal images to determine BioAge and screen for cardiovascular diseases. The team creates and refines software applications, integrates advanced AI algorithms, ensures the accuracy and reliability of diagnostic outputs, and continuously improves the user experience and technical efficacy of the platforms.

Engineering and Development Team

The Leadership Team at Toku Eyes comprises senior executives responsible for defining and steering the company's vision and strategic objectives. They ensure regulatory compliance, drive commercial strategy, oversee product development, and foster innovation in AI-driven retinal imaging solutions for preventive healthcare. Their collective expertise supports Toku's mission of enabling early and accurate diagnosis of health conditions through non-invasive retinal imaging, thereby empowering individuals to make informed health choices.

Toku Eyes

Org chart

Teams

Engineering and Development Team

Leadership Team

Offices

Toku Eyes

Org chart

Teams

Engineering and Development Team

Leadership Team

Offices

Related companies